Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MANCUSO, Salvatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.441
EU - Europa 1.987
AS - Asia 949
AF - Africa 12
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 9.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.431
IT - Italia 751
CN - Cina 506
SG - Singapore 319
DE - Germania 265
FI - Finlandia 227
UA - Ucraina 217
IE - Irlanda 124
SE - Svezia 100
GB - Regno Unito 91
RU - Federazione Russa 71
RO - Romania 30
IN - India 27
FR - Francia 25
BE - Belgio 21
IR - Iran 19
TR - Turchia 17
KR - Corea 14
CH - Svizzera 13
NL - Olanda 13
CA - Canada 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 9
PK - Pakistan 9
BR - Brasile 7
EU - Europa 7
HK - Hong Kong 7
AT - Austria 6
GR - Grecia 6
ID - Indonesia 6
JP - Giappone 5
PL - Polonia 5
BG - Bulgaria 4
ES - Italia 4
VN - Vietnam 4
BD - Bangladesh 2
IQ - Iraq 2
LB - Libano 2
SI - Slovenia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 9.407
Salva come PNG Salva come JPEG
Città #
Fairfield 1.075
Ashburn 661
Chandler 532
Woodbridge 500
Houston 477
Wilmington 438
Seattle 378
Cambridge 362
Ann Arbor 269
Singapore 256
Medford 160
Des Moines 148
Dublin 124
Palermo 124
Nanjing 104
Altamura 103
Princeton 103
Jacksonville 94
Dearborn 81
Beijing 79
Lawrence 73
San Diego 63
Boardman 48
Tulsa 42
New York 40
Ludwigshafen am Rhein 39
Santa Clara 37
Milan 35
Shenyang 35
Rome 30
Columbus 28
Hebei 28
Helsinki 27
Nanchang 27
Ningbo 22
Tianjin 22
Brussels 21
Jinan 21
Changsha 20
Jiaxing 20
London 20
Venice 17
Zhengzhou 16
Bremen 15
Guangzhou 15
San Paolo di Civitate 15
Kumar 14
Los Angeles 14
Redwood City 14
Tehran 14
Hangzhou 13
Saint Petersburg 12
Abidjan 10
Chicago 10
Piscataway 10
Washington 10
Fuzhou 9
Izmir 9
Kunming 8
Treviso 8
San Jose 7
Seongnam 7
Verona 7
Haikou 6
Hefei 6
Kilburn 6
Torino 6
Bologna 5
Brno 5
Central 5
Cesena 5
Dallas 5
Kiev 5
Lappeenranta 5
Orange 5
Pune 5
Redmond 5
Sciara 5
Shanghai 5
Toronto 5
Catania 4
Cincinnati 4
Edinburgh 4
Hanoi 4
Jakarta 4
Messina 4
Moscow 4
Phoenix 4
Rawalpindi 4
San Mateo 4
Taizhou 4
Turin 4
Amsterdam 3
Deiva Marina 3
Groningen 3
Gualdo Tadino 3
Hanover 3
Indiana 3
Munich 3
New Bedfont 3
Totale 7.181
Salva come PNG Salva come JPEG
Nome #
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 348
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 263
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 194
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 187
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 183
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical hodgkin lymphoma and correlation with early FDG-PET assessment 179
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 169
Acquired haemophilia in cancer: A systematic and critical literature review 155
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome 151
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 150
Immunosenescence and lymphomagenesis 148
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 147
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 141
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 136
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 134
Cardio-oncology in multiple myeloma: is it time for a specific focus? 129
Comprehensive Geriatric Assessment is an essential tool to support treatment decisions in elderly patients with Diffuse Large B Cell Lymphoma: A prospective multicenter evaluation on 173 patients by the Lymphoma Italian Foundation (FIL) 127
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 126
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 124
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 121
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 117
Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by Sequence Analysis of gag, pol, and env genes 115
DETECTION OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY, ITALY 115
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 112
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 111
Lymphomas and thyroid: Bridging the gap 109
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 109
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study. 108
Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica [Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area] 105
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: A cross-sectional analysis 104
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). 100
Cardiovascular risk factor in MPN patients 100
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): Analysis of the incidence of newly acquired hepatitis B infection and syphilis 99
A novel methodology for large-scale phylogeny partition 99
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 99
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? 99
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 99
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 96
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 96
Screening sierologico per l'infantum in soggetti HIV+ in area endemica Sicilia occidentale 94
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 94
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting 93
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe 92
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 92
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE 91
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 90
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 89
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 88
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 86
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 86
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration 85
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 84
Dimagrimento e diarrea: oltre la "wasting syndrome" 83
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 83
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy 83
Lymphonodal amyloidosis: case report 82
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 82
Chronic myeloid leukemia as second malignancy; a retrospective multicentrico study 81
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 79
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 78
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 78
BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY 76
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol 76
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 76
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-trifluoromethyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-one 75
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 74
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 74
RICERCA DI GIARDIA, CRYPTOSPORIDIUM E ISOSPORA IN SOGGETTI HIV POSITIVI 73
MOLECULAR EPIDEMIOLOGY OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY 73
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY 73
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS 70
BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA 70
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION 70
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: Not All AIDS-defining conditions are created equal 70
INFEZIONE DA HIV E IMMIGRATI NEGLI ULTIMI CINQUE ANNI DI ATTIVITA' DEL NOSTRO CENTRO 67
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 65
E' la pneumocistosi ancora presente in pazienti HIV positivi in epoca HAART? 64
Molecular epidemiology of HIV type 1 (HIV-1) non-B subtypes in SIcily 64
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 64
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 63
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 63
Prevalence of Giardia, Cryptosporidium and Isospora in HIv-seropositive individuals in Sicily. 62
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 60
Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study 58
“Evidence of HIV-1 second-generation recombinant strains (SGRs) in Sicily: sequence analysis of gag, pol, and env genes.” 57
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 56
Bone damage after chemotherapy for lymphoma: a real-world experience 56
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 56
Chronic myeloid leukemia as second malignancy; restrospective multicentric study 55
LONG TERM RESULTS OF STANFORD V REGIMEN AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN 59 PATIENTS (PTS) WITH HD AND HIV INFECTION (HD-HIV) 55
VALIDITA' DEL METODO DI IMMUNOFLUORESCENZA DIRETTA NELLA DIAGNOSI DI GIARDIASI IN UN SOGGETTO HIV+ 54
CASO CLINICO 51
VEBEP REGIMEN IN PATIENTS (PTS) WITH HD AND HIV INFECTION(HD-HIV): FINAL RESULTS OF A PHASE II STUDY OF THE ITALIAN COOPERATIVE GROUP ON AIDS AND TUMORS (GICAT) 50
AIDS AND SURGICAL PATIENTS 49
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk" 49
Familial essential thrombocythemia: 6 cases from a mono‐institutional series 48
Pre-emptive treatment with cidofovir for Cytomegalovirus antigenemia in autologous bone marrow recipients and CLL patients on therapy with alemtuzumab 47
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma 46
LA TERAPIA DELL'HIV IN STADIO AVANZATO IN CORSO DI EPATITE CRONICA DA HCV 45
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy 43
Totale 9.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.447 0 0 0 0 0 367 283 166 221 140 195 75
2020/20211.947 77 146 303 301 171 80 102 116 158 209 142 142
2021/20221.204 102 222 28 49 19 57 63 68 139 187 73 197
2022/20231.597 155 299 29 164 172 259 107 127 183 27 48 27
2023/2024737 29 103 61 103 55 139 76 24 6 19 18 104
2024/2025539 57 96 74 177 92 43 0 0 0 0 0 0
Totale 9.912